Video Player is loading.
Current Time 0:00
Duration -:-
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • descriptions off, selected
    • captions off, selected

      Green Orange Blue Creative Healthcare Facility Presentation

      Published on Slideshow
      Static slideshow
      Download PDF version
      Download PDF version
      Embed video
      Share video
      Ask about this video

      Scene 1 (0s)

      IDOSE TR. Role play between medical rep and.

      Scene 2 (7s)

      MEDICAL REP. GOOD MORNING, DR. SMITH. I HOPE YOU'RE DOING WELL TODAY..

      Scene 3 (19s)

      Doctor. I've heard a bit about iDose TR. What makes it stand out from other treatments for glaucoma?.

      Scene 4 (38s)

      Medical rep. iDose TR is a sustained-release implant that delivers a consistent dose of medication directly into the eye over an extended period of time. It offers a unique advantage by providing a continuous therapeutic effect, reducing the need for frequent administration of eye drops. Plus, it comes in different doses, allowing for personalized treatment plans tailored to each patient's specific needs..

      Scene 5 (59s)

      Medical rep. There have been several clinical trials evaluating the effectiveness of iDose TR, all conducted by Glaukos Corporation. One study published in the Journal of Glaucoma compared iDose TR to topical eye drops and found that patients receiving iDose TR had significantly lower IOP levels and required fewer additional medications. to control their glaucoma. Additionally, another study published in the American Journal of Ophthalmology demonstrated that iDose TR had a favorable safety profile with minimal adverse events reported..

      Scene 6 (1m 25s)

      Doctor. Impressive. And what about the cost?. While the initial cost of iDose TR may be higher than traditional eye drop therapies, it's essential to consider the long-term benefits and potential cost savings. With iDose TR's sustained-release mechanism, patients may require fewer additional medications and fewer office visits for medication adjustments over time. Additionally, many insurance plans cover iDose TR, so it's worth checking with individual insurance providers to understand coverage options..

      Scene 7 (1m 48s)

      Doctor. What about potential side effects?. Medical rep.

      Scene 8 (2m 13s)

      Doctor. Thank you for providing this comprehensive overview. I'm definitely interested in incorporating iDose TR into my treatment options for glaucoma patients. Can you tell me more about the different doses available and how they fit into the treatment plan?.

      Scene 9 (2m 41s)

      IT. That makes sense. Thank you for clarifying. Please provide me with more information, including dosing guidelines and educational materials, so I can further explore incorporating iDose TR into my practice..